Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)

Movement Disorders

Volumn 11, Issue 2, 1996, Pages 143-150

  Quinn, Niall ^a   Brown, Richard ^a   Craufurd, David ^b   Goldman, Serge ^c   Hodges, John ^d   Kieburtz, Karl ^e   Lindvall, Olle ^f   MacMillan, John ^g   Roos, Raymund ^h  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c ERASME HOSPITAL   (Belgium)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Huntington's disease; Neural transplantation; Striatal grafting

Indexed keywords

ARTICLE; CELL TRANSPLANTATION; CLINICAL PROTOCOL; CORPUS STRIATUM; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; PRIORITY JOURNAL;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; HUNTINGTON DISEASE; NERVE REGENERATION; NEUROLOGIC EXAMINATION; NEURONAL PLASTICITY; NEUROPSYCHOLOGICAL TESTS; RESEARCH; TREATMENT OUTCOME;

EID: 0029930390     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110205     Document Type: Article

References (44)

1. CAPIT committee: Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
2. Harper PS, ed. Huntington's disease. London: Saunders, 1991.
3. Isacson O, Dunnett SB, Björklund A. Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc Natl Acad Sci USA 1986;83:2728-2732.
4. Dunnett SB, Isacson O, Sirinathsinghji DJS, Clarke DJ, Björklund A. Striatal grafts in rats with unilateral neostriatal lesions. III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 1988;24:813-820.
5. Sirinathsinghji DJS, Dunnett SB, Isacson O, Clarke DJ, Kendrick K, Björklund A. Striatal grafts in rats with unilateral neostriatal lesions. II. In vivo monitoring of GABA release in globus pallidus and substantia nigra. Neuroscience 1988;24:803-811.
6. Hantraye P, Riche D, Mazière M, Isacson O. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington's disease. Proc Natl Acad Sci USA 1992;89:4187-4191.
7. Wictorin K. Anatomy and connectivity of intrastriatal striatal transplants. Prog Neurobiol 1992;38:611-639.
8. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
9. Warner JP, Barron LH, Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993;7:235-239.
10. Huntington Study Group. The Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
11. Folstein MF, Folstein SE, McHugh PR. Mini mental state: a practical guide for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Wilson B, Cockburn J, Baddeley A. The Rivermead Behavioural Memory Test. Bury St. Edmunds: Thames Valley Test Co., 1985.
13. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-142.
14. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corp., 1981.
15. Milner B. Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 1971;27:272-277.
16. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Boston: Kaplan and Goodglass, 1978.
17. Hodges JR, Salmon DP, Butters N. The nature of the naming deficit in Alzheimer's and Huntington's disease. Brain 1991; 114:1547-1558.
18. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use with Alzheimer's disease. J Gerontol 1992;47:154-158.
19. De Renzi E, Faglioni P. Normative data and screening power of a shortened version of the Token Test. Cortex 1978;14:41-49.
20. Warrington EK, James M. Visual Object and Space Perception Battery. Bury St. Edmunds: Thames Valley Test Co., 1991.
21. Benton AL, Hamsher K deS. Multilingual Aphasia Examination. Iowa City: University of Iowa Press, 1976.
22. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
23. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313-324.
24. Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 1968;3:83-91.
25. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8:271-276.
26. Cambridge Neuropsychological Test Automated Battery manual. Cambridge: Paul Fray, 1991.
27. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995;58:598-606.
28. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellack L. Karusu TB, eds. Geriatric psychiatry. New York: Grune and Stratton, 1976: 77-121.
29. Nelson HE, Willison J. National Adult Reading Test. 2nd ed. Windsor: NFER-Nelson, 1991.
30. Craufurd D, Snowden JS. Manchester Problem Behaviours Assessment (in preparation).
31. Beck AT, Ward CH, Mendelson N, Moch J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
32. Spielberger CD. Manual of the State-Trait Anxiety Inventory. Oxford: Oxford Psychologists Press, 1983.
33. World Health Organisation. Composite International Diagnostic Interview 1.1. Computer Manual. Geneva: World Health Organisation, 1993.
34. Antonini A, Weindl A, Leenders KL. Brain glucose metabolism and striatal dopamine receptor density in subjects genetically at risk for Huntington's disease (HD) measured with positron emission tomography (PET). Neurology 1993; 43:A335.
35. 2 receptor status in chorea. Neurology 1993;43: A333.
36. 18FDG and computed tomographic scan. Ann Neurol 1982;12:425-434.
37. 1 receptor number - a sensitive PET marker for early brain degeneration in Huntington's disease. Eur Arch Psychiatry Clin Neurosci 1993;243:249-255.
38. Oepen G, Doerr M, Thoden U. Visual (VEP) and somatosensory (SSEP) evoked potentials in Huntington's chorea. Electroencephalogr Clin Neurophysiol 1981;51:666-670.
39. Noth J, Friedemann H-H, Podoll K, Lange HW. Absence of long latency reflexes to imposed finger displacements in patients with Huntington's disease. Neurosci Lett 1983;35:97-100.
40. Avanzini G, Girotti F, Caraceni T, Spreafico R. Oculomotor disorders in Huntington's chorea. J Neurol Neurosurg Psychiatry 1979;42:581-589.
41. Boer GJ, on behalf of the Network of European CNS Transplantation and Restoration (NECTAR). Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. J Neurol 1994;242:1-13.
42. O'Rahilly R, Muller F. Developmental stages in human embryos. Publication 637. Washington, DC: Carnegie Institution of Washington, 1987.
43. Hern WM. Correlation of fetal age and measurements between 10 and 26 weeks of gestation. Obstet Gynecol 1984; 63:26-32.
44. Drumm JE, O'Rahilly R. The assessment of prenatal age from the crown-rump length determined ultrasonically. Am J Anat 1977;148:550-560.